Group One Trading’s enGene Therapeutics ENGN Stock Holding History
Bought
Maintained
Sold
Other funds holding ENGN
BCM
SL
ACA
Group One Trading's ENGN Position: Q3 2026 in Review
Group One Trading opened a new position in enGene Therapeutics (ENGN) in Q3 2026: 215 shares worth $430. The stake represents ﹤0.01% of the portfolio and ranks #7654 among its holdings.
60 funds tracked by Wall St. Rank hold ENGN as of Q3 2026.
- Group One Trading held 215 shares of enGene Therapeutics worth $430 as of Q3 2026.
- enGene Therapeutics was a new Group One Trading position in Q3 2026.
- enGene Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #7654 holding.
- 60 funds tracked by Wall St. Rank held enGene Therapeutics as of Q3 2026.
Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.